المؤلفون: Pinato DJ; Department of Surgery and Cancer, Imperial College London, Hammersmith Hospital, London, UK; Division of Oncology, Department of Translational Medicine, University of Piemonte Orientale, Novara, Italy. Electronic address: david.pinato@imperial.ac.uk., Tabernero J; Medical Oncology, Vall d'Hebron University Hospital and Institute of Oncology, Barcelona, Spain., Bower M; Department of Oncology, Chelsea and Westminster Hospital, London, UK; National Centre for HIV Malignancy, Chelsea and Westminster Hospital, London, UK., Scotti L; Unit of Medical Statistics, Department of Translational Medicine, University of Piemonte Orientale, Novara, Italy., Patel M; Department of Surgery and Cancer, Imperial College London, Hammersmith Hospital, London, UK., Colomba E; Department of Cancer Medicine, Institut Gustave Roussy, University of Paris Saclay, Villejuif, France., Dolly S; Medical Oncology, Guy's and St Thomas' NHS Foundation Trust, London, UK., Loizidou A; Department of Infectious Diseases, Internal Medicine, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium., Chester J; Medical Oncology, School of Medicine, Cardiff University, Cardiff, UK; Medical Oncology, Velindre Cancer Centre, Cardiff, UK., Mukherjee U; Medical Oncology, Barts Health NHS Trust, London, UK., Zambelli A; Oncology Unit, Azienda Socio Sanitaria Territoriale Papa Giovanni XXIII, Bergamo, Italy., Dalla Pria A; Department of Oncology, Chelsea and Westminster Hospital, London, UK; National Centre for HIV Malignancy, Chelsea and Westminster Hospital, London, UK., Aguilar-Company J; Medical Oncology, Vall d'Hebron University Hospital and Institute of Oncology, Barcelona, Spain., Ottaviani D; Cancer Division, University College London Hospitals, London, UK., Chowdhury A; Cancer Division, University College London Hospitals, London, UK., Merry E; Cancer Division, University College London Hospitals, London, UK., Salazar R; Department of Medical Oncology, ICO L'Hospitalet, Oncobell Program, Hospitalet de Llobregat, Barcelona, Spain., Bertuzzi A; Medical Oncology and Hematology Unit, Humanitas Cancer Center, IRCCS Humanitas Research Hospital, Rozzano, Milan, Italy., Brunet J; Department of Medical Oncology, Catalan Institute of Oncology, University Hospital Josep Trueta, Girona, Spain., Lambertini M; Medical Oncology Department, IRCCS Ospedale Policlinico San Martino, Genova, Italy; Department of Internal Medicine and Medical Specialties, School of Medicine, University of Genova, Genova, Italy., Tagliamento M; Medical Oncology Department, IRCCS Ospedale Policlinico San Martino, Genova, Italy; Department of Internal Medicine and Medical Specialties, School of Medicine, University of Genova, Genova, Italy., Pous A; Department of Medical Oncology, Catalan Institute of Oncology, University Hospital Josep Trueta, Girona, Spain., Sita-Lumsden A; Medical Oncology, Guy's and St Thomas' NHS Foundation Trust, London, UK., Srikandarajah K; Medical Oncology, Guy's and St Thomas' NHS Foundation Trust, London, UK., Colomba J; Department of Cancer Medicine, Institut Gustave Roussy, University of Paris Saclay, Villejuif, France., Pommeret F; Department of Cancer Medicine, Institut Gustave Roussy, University of Paris Saclay, Villejuif, France., Seguí E; Department of Medical Oncology, Hospital Clinic, Barcelona, Spain., Generali D; Multidisciplinary Breast Pathology and Translational Research Unit, Azienda Socio Sanitaria Territoriale Cremona, Cremona, Italy; Department of Medical, Surgical and Health Sciences, University of Trieste, Trieste, Italy., Grisanti S; Medical Oncology Unit, Spedali Civili, Brescia, Italy; Medical Oncology Unit, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy., Pedrazzoli P; Department of Internal Medicine and Medical Therapy, University of Pavia, Pavia, Italy., Rizzo G; Medical Oncology Unit, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy., Libertini M; Medical Oncology Unit, Fondazione Poliambulanza Istituto Ospedaliero, Brescia, Italy., Moss C; Translational Oncology and Urology Research, School of Cancer and Pharmaceutical Sciences, King's College London, London, UK., Evans JS; Department of Surgery and Cancer, Imperial College London, Hammersmith Hospital, London, UK., Russell B; Translational Oncology and Urology Research, School of Cancer and Pharmaceutical Sciences, King's College London, London, UK., Harbeck N; Department of Gynecology and Obstetrics, Breast Center and Gynecological Cancer Center and Comprehensive Cancer Center Munich, University Hospital Munich, Munich, Germany., Vincenzi B; Policlinico Universitario Campus Bio-Medico, Rome, Italy., Biello F; Division of Oncology, Department of Translational Medicine, University of Piemonte Orientale, Novara, Italy; Azienda Ospedaliera Maggiore Della Caritá, Novara, Italy., Bertulli R; Medical Oncology 2, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Liñan R; Department of Medical Oncology, Catalan Institute of Oncology, University Hospital Josep Trueta, Girona, Spain., Rossi S; Medical Oncology and Hematology Unit, Humanitas Cancer Center, IRCCS Humanitas Research Hospital, Rozzano, Milan, Italy., Carmona-García MC; Department of Medical Oncology, Catalan Institute of Oncology, University Hospital Josep Trueta, Girona, Spain., Tondini C; Oncology Unit, Azienda Socio Sanitaria Territoriale Papa Giovanni XXIII, Bergamo, Italy., Fox L; Haematology, Vall d'Hebron University Hospital and Institute of Oncology, Barcelona, Spain., Baggi A; Medical Oncology Unit, Spedali Civili, Brescia, Italy; Medical Oncology Unit, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy., Fotia V; Oncology Unit, Azienda Socio Sanitaria Territoriale Papa Giovanni XXIII, Bergamo, Italy., Parisi A; Department of Life, Health & Environmental Sciences, University of L'Aquila, L'Aquila, Italy., Porzio G; Department of Biotechnology and Applied Clinical Sciences, University of L'Aquila, L'Aquila, Italy., Saponara M; Melanoma and Sarcoma Medical Treatment Unit, Istituto Europeo di Oncologia, Milan, Italy., Cruz CA; Department of Medical Oncology, Hospital Clinic, Barcelona, Spain., García-Illescas D; Medical Oncology, Vall d'Hebron University Hospital and Institute of Oncology, Barcelona, Spain., Felip E; Department of Medical Oncology, Catalan Institute of Oncology, University Hospital Josep Trueta, Girona, Spain., Roqué Lloveras A; Department of Medical Oncology, Catalan Institute of Oncology, University Hospital Josep Trueta, Girona, Spain., Sharkey R; Department of Oncology, Chelsea and Westminster Hospital, London, UK; National Centre for HIV Malignancy, Chelsea and Westminster Hospital, London, UK., Roldán E; Medical Oncology, Vall d'Hebron University Hospital and Institute of Oncology, Barcelona, Spain., Reyes R; Department of Medical Oncology, Hospital Clinic, Barcelona, Spain., Earnshaw I; Cancer Division, University College London Hospitals, London, UK., Ferrante D; Unit of Medical Statistics, Department of Translational Medicine, University of Piemonte Orientale, Novara, Italy., Marco-Hernández J; Department of Internal Medicine, Hospital Clinic, Barcelona, Spain., Ruiz-Camps I; Infectious Diseases, Vall d'Hebron University Hospital and Institute of Oncology, Barcelona, Spain., Gaidano G; Division of Haematology, Department of Translational Medicine, University of Piemonte Orientale, Novara, Italy; Azienda Ospedaliera Maggiore Della Caritá, Novara, Italy., Patriarca A; Division of Haematology, Department of Translational Medicine, University of Piemonte Orientale, Novara, Italy; Azienda Ospedaliera Maggiore Della Caritá, Novara, Italy., Bruna R; Division of Haematology, Department of Translational Medicine, University of Piemonte Orientale, Novara, Italy; Azienda Ospedaliera Maggiore Della Caritá, Novara, Italy., Sureda A; Haematology Department, ICO L'Hospitalet, Oncobell Program, Hospitalet de Llobregat, Barcelona, Spain., Martinez-Vila C; Fundació Althaia Manresa, Manresa, Spain., Sanchez de Torre A; Hospital Universitario XII de Octubre, Madrid, Spain., Cantini L; Medical Oncology, Azienda Ospedaliero Universitaria, Ospedali Riuniti, Polytechnic University of the Marche Region, Ancona, Italy., Filetti M; Medical Oncology, Sant'Andrea Hospital, Rome, Italy., Rimassa L; Medical Oncology and Hematology Unit, Humanitas Cancer Center, IRCCS Humanitas Research Hospital, Rozzano, Milan, Italy; Department of Biomedical Sciences, Humanitas University, Milan, Italy., Chiudinelli L; Oncology Unit, Azienda Socio Sanitaria Territoriale Papa Giovanni XXIII, Bergamo, Italy., Franchi M; Oncology Unit, Azienda Socio Sanitaria Territoriale Papa Giovanni XXIII, Bergamo, Italy., Krengli M; Division of Radiotherapy, Department of Translational Medicine, University of Piemonte Orientale, Novara, Italy; Azienda Ospedaliera Maggiore Della Caritá, Novara, Italy., Santoro A; Medical Oncology and Hematology Unit, Humanitas Cancer Center, IRCCS Humanitas Research Hospital, Rozzano, Milan, Italy; Department of Biomedical Sciences, Humanitas University, Milan, Italy., Prat A; Department of Medical Oncology, Hospital Clinic, Barcelona, Spain; Translational Genomics and Targeted Therapies in Solid Tumors, IDIBAPS, Barcelona, Spain, Barcelona, Spain., Van Hemelrijck M; Translational Oncology and Urology Research, School of Cancer and Pharmaceutical Sciences, King's College London, London, UK., Diamantis N; Medical Oncology, Barts Health NHS Trust, London, UK., Newsom-Davis T; Department of Oncology, Chelsea and Westminster Hospital, London, UK; National Centre for HIV Malignancy, Chelsea and Westminster Hospital, London, UK., Gennari A; Division of Oncology, Department of Translational Medicine, University of Piemonte Orientale, Novara, Italy; Azienda Ospedaliera Maggiore Della Caritá, Novara, Italy., Cortellini A; Department of Surgery and Cancer, Imperial College London, Hammersmith Hospital, London, UK; Department of Biotechnology and Applied Clinical Sciences, University of L'Aquila, L'Aquila, Italy.

مؤلفون مشاركون: OnCovid study group

المصدر: The Lancet. Oncology [Lancet Oncol] 2021 Dec; Vol. 22 (12), pp. 1669-1680. Date of Electronic Publication: 2021 Nov 03.

نوع المنشور: Clinical Trial; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Lancet Pub. Group Country of Publication: England NLM ID: 100957246 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1474-5488 (Electronic) Linking ISSN: 14702045 NLM ISO Abbreviation: Lancet Oncol Subsets: MEDLINE

مواضيع طبية MeSH: COVID-19/*complications , Neoplasms/*epidemiology, Adult ; Aged ; Aged, 80 and over ; Antineoplastic Agents/therapeutic use ; Belgium ; COVID-19/epidemiology ; COVID-19/mortality ; Disease Progression ; Female ; France ; Germany ; Hospitalization ; Humans ; Italy ; Kaplan-Meier Estimate ; Male ; Middle Aged ; Neoplasms/complications ; Neoplasms/drug therapy ; Prevalence ; Registries ; Retrospective Studies ; Spain ; United Kingdom ; Post-Acute COVID-19 Syndrome